Abstract
Quantitative structure–activity relationships (QSARs) are empirical statistical models commonly used by medicinal chemists in compound design. They have had a long history of successful use in the pharmaceutical industry, and developed out of an even longer history of quantitative structure–reactivity relationships in physical organic chemistry. Originally, QSARs were used to model within close homologous series, but they have become more widely useful in modelling drug metabolism and pharmacokinetic properties across project series, which brings new challenges. Assessment of quality of the QSAR model, and its ability to make accurate and precise predictions for a particular chemical series, is a critical question for medicinal chemists. This chapter describes good practice in building and validating QSAR models, and also some of the common language used in building and validating QSAR models, to aid the dialog between medicinal chemists and computational chemists. QSAR model building can appear to medicinal chemists as a collection of intimidating statistical technologies and hard to interpret molecular descriptors. Visual inspection of structure–activity relationships through graphing physical properties vs activity, often a prelude to QSAR modelling is highlighted as a very powerful technique in itself. Matched molecular pair analysis, an “inverse QSAR” method, is also described, and high impact examples of successful QSARs and useful QSAR tools, freely available on the internet, are highlighted.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.